WHWK / Whitehawk Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Whitehawk Therapeutics, Inc.
US ˙ NasdaqCM ˙ US00032Q1040

Deler fremragende 47,196,564 shares
Insideraktier31.210.761 shares
Insider ejerskab66,13 %
Total Insiders33
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-3 ( )
10163 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-3.945% ( )
10798 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Whitehawk Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Behzad Aghazadeh Director, 10% Owner - [D] [10%] 3.471.752 3.471.752
Avoro Ventures LLC Director - [D] 300.000 3.471.752
Bryan Ball See remarks - [O] 397.106 397.106
Caley Castelein Director - [D] 2.165.998 2.165.998
Cheryl Cohen Director - [D] 16.160 16.160
Dhaval Desai Chief Strategy Officer - [O] 150.684 150.684
Anupam Dalal Director - [D] 3.411.532 3.411.532
Brendan Delaney Chief Operating Officer - [O] 20.000 20.000
Neil Desai EXECUTIVE CHAIRMAN, Director - [D] [O] 1.171.543 1.171.543
Pravin Dugel Director - [D] 12.568 12.568
Gardner Joseph H. President, Director - [D] [O] 453.019 453.019
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Giacobello Scott M. CHIEF FINANCIAL OFFICER - [O] 295.224 295.224
Stephen J Hoffman Chief Executive Officer, Director - [D] [O] 31.967 31.967
Hehenberger Karin M. 17.549
Samuel D Isaly Director, 10% Owner - [D] [10%] 7.306.902 4.416.446
Lorettta M Itri Chief Medical Officer - [O] 3.000 3.000
Chau Quang Khuong Director, 10% Owner - [D] [10%] 5.193.946 5.193.946
David James Lennon CHIEF EXECUTIVE OFFICER, Director - [D] [O] 518.622 518.622
James B Murphy 0
Regina Marek Vice President of Finance - [O] 23.250 23.250
Richard E Maroun 17.549
Ag Novartis 10% Owner - [10%] 4.049.804 4.049.804
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bioventures Ltd Novartis 10% Owner - [10%] 4.049.804 4.049.804
Orbimed Advisors Llc 10% Owner - [10%] 0 0
OrbiMed Capital GP V LLC Director, 10% Owner - [D] [10%] 0 0
Steve Pakola 125.000
Peters Kevin G. Chief Scientific Officer - [O] 320.536 320.536
Steven Prelack Director - [D] 24.485 24.485
Michael W Rogers 430.500
Emma Reeve 16.486
Muneer A Satter Director, 10% Owner - [D] [10%] 5.621.835 5.621.835
Paul M Weiss Director - [D] 2.607.730 2.607.730
Baiteng Zhao Director - [D] 1.250.000 1.250.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i WHWK / Whitehawk Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-08-26 Dalal Anupam 1.529.402 13,0770 101.960 196,1550 19.999.990 27 32.66 -16.669.975 -83,35
2021-08-26 Castelein Caley 259.998 13,0770 17.333 196,1550 3.399.994
2019-07-10 Gardner Joseph H. 5.000 0,8147 333 12,2205 4.074
2019-07-03 Gardner Joseph H. 5.000 0,8970 333 13,4550 4.485
2019-01-10 Satter Muneer A 23.818 2,4537 1.588 36,8055 58.442
2019-01-09 Satter Muneer A 20.000 2,3938 1.333 35,9070 47.876
2019-01-08 Satter Muneer A 20.000 2,1986 1.333 32,9790 43.972
2019-01-07 Satter Muneer A 20.000 2,1779 1.333 32,6685 43.558
2019-01-04 Satter Muneer A 20.000 2,1198 1.333 31,7970 42.396

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

WHWK / Whitehawk Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i WHWK / Whitehawk Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-04-16 Giacobello Scott M. 141.600 4,1300 141.600 4,1300 584.808 15 3.9900 -19.824 -3,39
2026-04-15 Giacobello Scott M. 77.000 3,8600 77.000 3,8600 297.220
2026-04-14 BALL BRYAN 92.460 3,6400 92.460 3,6400 336.554
2026-04-13 BALL BRYAN 26.389 3,4600 26.389 3,4600 91.306
2026-04-10 BALL BRYAN 6.596 3,4300 6.596 3,4300 22.624
2026-04-09 BALL BRYAN 50.000 3,5700 50.000 3,5700 178.500
2026-04-09 Lennon David James 14.500 3,3800 14.500 3,3800 49.010
2026-04-08 Lennon David James 63.945 3,4000 63.945 3,4000 217.413
2026-04-07 Lennon David James 94.087 3,4300 94.087 3,4300 322.718

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

WHWK / Whitehawk Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-17 2026-04-16 4 Giacobello Scott M. WHWK Common Stock S - Sale D 4,1300 -141.600 -585 295.224
2026-04-17 2026-04-15 4 Giacobello Scott M. WHWK Common Stock S - Sale D 3,8600 -77.000 -297 436.824
2026-04-15 2026-04-14 4 BALL BRYAN WHWK Common Stock S - Sale D 3,6400 -92.460 -337 397.106
2026-04-15 2026-04-13 4 BALL BRYAN WHWK Common Stock S - Sale D 3,4600 -26.389 -91 489.566
2026-04-13 2026-04-10 4 BALL BRYAN WHWK Common Stock S - Sale D 3,4300 -6.596 -23 515.955
2026-04-13 2026-04-09 4 BALL BRYAN WHWK Common Stock S - Sale D 3,5700 -50.000 -178 522.551
2026-04-10 2026-04-09 4 Lennon David James WHWK Common Stock S - Sale D 3,3800 -14.500 -49 518.622
2026-04-08 2026-04-08 4 Lennon David James WHWK Common Stock S - Sale D 3,4000 -63.945 -217 533.122
2026-04-08 2026-04-07 4 Lennon David James WHWK Common Stock S - Sale D 3,4300 -94.087 -323 597.067
2026-04-08 2026-04-06 4 Lennon David James WHWK Common Stock S - Sale D 3,5100 -102.395 -359 691.154
2026-04-03 2026-04-01 4 BALL BRYAN WHWK Common Stock M - Exercise D 366.532 572.551
2026-04-03 2026-04-01 4 Giacobello Scott M. WHWK Common Stock M - Exercise D 473.902 502.002
2026-04-03 2026-04-02 4 Lennon David James WHWK Common Stock S - Sale D 3,4800 -26.858 -93 793.549
2026-04-03 2026-04-01 4 Lennon David James WHWK Common Stock M - Exercise D 775.828 820.407
2026-03-10 2026-03-02 4 BALL BRYAN WHWK Common Stock S - Sale D 3,3096 -1.834 -6 206.019
2026-03-10 2026-03-01 4 BALL BRYAN WHWK Common Stock M - Exercise D 5.000 207.853
2026-03-10 2026-03-02 4 Lennon David James WHWK Common Stock S - Sale D 3,3096 -5.100 -17 44.579
2026-03-10 2026-03-01 4 Lennon David James WHWK Common Stock M - Exercise D 16.250 49.679
2026-03-10 2026-03-02 4 Giacobello Scott M. WHWK Common Stock S - Sale D 3,3096 -2.594 -9 28.100
2026-03-10 2026-03-01 4 Giacobello Scott M. WHWK Common Stock M - Exercise D 6.750 30.694
2025-03-05 2025-03-04 4 Dalal Anupam AADI Common Stock A - Award I 2,4000 1.561.000 3.746 3.410.402
2025-03-04 2025-03-04 4 Castelein Caley AADI Common Stock A - Award I 2,4000 1.666.000 3.998 2.165.998
2025-03-04 2025-03-04 4 Zhao Baiteng AADI Common Stock A - Award I 2,4000 1.250.000 3.000 1.250.000
2025-03-04 2025-03-04 4 BALL BRYAN AADI Common Stock A - Award D 2,4000 100.000 240 202.853
2025-03-04 2025-03-03 4 BALL BRYAN AADI Common Stock S - Sale D 2,3500 -2.147 -5 102.853
2025-03-04 2025-03-01 4 BALL BRYAN AADI Common Stock M - Exercise D 5.000 105.000
2025-03-03 2025-03-03 4 Giacobello Scott M. AADI Common Stock S - Sale D 2,3500 -2.806 -7 23.944
2025-03-03 2025-03-01 4 Giacobello Scott M. AADI Common Stock M - Exercise D 6.750 26.750
2025-03-03 2025-03-03 4 Lennon David James AADI Common Stock S - Sale D 2,3500 -5.690 -13 33.429
2025-03-03 2025-03-01 4 Lennon David James AADI Common Stock M - Exercise D 16.250 39.119
2024-10-03 2024-10-03 4 Lennon David James AADI Common Stock S - Sale D 1,9400 -9.689 -19 22.869
2024-10-03 2024-10-02 4 Lennon David James AADI Common Stock M - Exercise D 32.558 32.558
2024-09-05 2024-09-03 4 Desai Neil AADI Common Stock S - Sale I 1,7079 -40.000 -68 1.171.543
2024-08-05 2024-08-05 4 Desai Neil AADI Common Stock S - Sale I 1,3437 -5.652 -8 1.211.543
2024-08-05 2024-08-02 4 Desai Neil AADI Common Stock S - Sale I 1,4105 -18.933 -27 1.217.195
2024-08-05 2024-08-01 4 Desai Neil AADI Common Stock S - Sale I 1,4956 -15.415 -23 1.236.128
2024-07-02 2024-07-02 4 Desai Neil AADI Common Stock S - Sale I 1,3421 -8.652 -12 1.251.543
2024-07-02 2024-07-01 4 Desai Neil AADI Common Stock S - Sale I 1,4548 -31.348 -46 1.260.195
2024-06-05 2024-06-04 4 Desai Neil AADI Common Stock S - Sale I 1,7674 -20.225 -36 1.291.543
2024-06-05 2024-06-03 4 Desai Neil AADI Common Stock S - Sale I 1,8086 -19.775 -36 1.311.768
2024-05-01 2024-05-01 4 Desai Neil AADI Common Stock S - Sale I 1,9296 -40.000 -77 1.331.543
2024-04-26 3 BALL BRYAN AADI Common Stock D 100.000
2024-04-03 2024-04-02 4 Desai Neil AADI Common Stock S - Sale I 2,2275 -22.228 -50 1.371.543
2024-04-03 2024-04-01 4 Desai Neil AADI Common Stock S - Sale I 2,3127 -17.772 -41 1.393.771
2024-03-04 2024-03-04 4 Desai Neil AADI Common Stock S - Sale I 2,0994 -14.964 -31 1.411.543
2024-03-04 2024-03-01 4 Desai Neil AADI Common Stock S - Sale I 1,9687 -27.036 -53 1.426.507
2024-02-02 2024-02-01 4 Desai Neil AADI Common Stock S - Sale I 1,7445 -42.000 -73 1.453.543
2024-01-02 2024-01-02 4 Desai Neil AADI Common Stock S - Sale I 2,0607 -42.000 -87 1.495.543
2023-12-07 2023-12-06 4 Desai Neil AADI Common Stock S - Sale I 4,8194 -7.037 -34 1.537.543
2023-12-05 2023-12-05 4 Desai Neil AADI Common Stock S - Sale I 5,0153 -15.740 -79 1.544.580
2023-12-05 2023-12-04 4 Desai Neil AADI Common Stock S - Sale I 5,1477 -10.876 -56 1.560.320
2023-12-05 2023-12-01 4 Desai Neil AADI Common Stock S - Sale I 5,1373 -8.347 -43 1.571.196
2023-11-02 2023-11-02 4 Desai Neil AADI Common Stock S - Sale I 4,4566 -31.662 -141 1.579.543
2023-11-02 2023-11-01 4 Desai Neil AADI Common Stock S - Sale I 4,3185 -10.338 -45 1.611.205
2023-10-03 2023-10-03 4 Desai Neil AADI Common Stock S - Sale I 4,0961 -16.431 -67 1.621.543
2023-10-03 2023-10-02 4 Desai Neil AADI Common Stock S - Sale I 4,3685 -25.569 -112 1.637.974
2023-09-06 2023-09-06 4 Desai Neil AADI Common Stock S - Sale I 5,2928 -7.111 -38 1.663.543
2023-09-06 2023-09-05 4 Desai Neil AADI Common Stock S - Sale I 5,6341 -21.000 -118 1.670.654
2023-09-06 2023-09-01 4 Desai Neil AADI Common Stock S - Sale I 5,9668 -13.889 -83 1.691.654
2023-08-03 2023-08-02 4 Desai Neil AADI Common Stock S - Sale I 5,1970 -19.290 -100 1.705.543
2023-08-03 2023-08-01 4 Desai Neil AADI Common Stock S - Sale I 5,2190 -22.710 -119 1.724.833
2023-07-06 2023-07-06 4 Desai Neil AADI Common Stock S - Sale I 6,2716 -15.829 -99 1.747.543
2023-07-06 2023-07-05 4 Desai Neil AADI Common Stock S - Sale I 6,5471 -16.171 -106 1.763.372
2023-07-06 2023-07-03 4 Desai Neil AADI Common Stock S - Sale I 6,6446 -10.000 -66 1.779.543
2023-06-06 2023-06-06 4 Desai Neil AADI Common Stock S - Sale I 8,1891 -7.260 -59 1.789.543
2023-06-05 2023-06-05 4 Desai Neil AADI Common Stock S - Sale I 8,1096 -17.315 -140 1.796.803
2023-06-05 2023-06-02 4 Desai Neil AADI Common Stock S - Sale I 7,9901 -12.443 -99 1.814.118
2023-06-05 2023-06-01 4 Desai Neil AADI Common Stock S - Sale I 7,9222 -4.982 -39 1.826.561
2023-05-05 2023-05-04 4 Desai Neil AADI Common Stock S - Sale I 7,5682 -2.305 -17 1.831.543
2023-05-03 2023-05-03 4 Desai Neil AADI Common Stock S - Sale I 7,6768 -7.695 -59 1.833.848
2023-05-03 2023-05-02 4 Desai Neil AADI Common Stock S - Sale I 7,4757 -7.521 -56 1.841.543
2023-05-03 2023-05-01 4 Desai Neil AADI Common Stock S - Sale I 7,7983 -24.479 -191 1.849.064
2023-04-06 2023-04-06 4 Desai Neil AADI Common Stock S - Sale I 7,0927 -12.212 -87 1.873.543
2023-04-05 2023-04-05 4 Desai Neil AADI Common Stock S - Sale I 7,2350 -7.336 -53 1.885.755
2023-04-05 2023-04-04 4 Desai Neil AADI Common Stock S - Sale I 7,3029 -12.869 -94 1.893.091
2023-04-05 2023-04-03 4 Desai Neil AADI Common Stock S - Sale I 7,4460 -9.583 -71 1.905.960
2022-09-27 2022-09-26 4 Castelein Caley AADI Common Stock A - Award I 12,5000 240.000 3.000 499.998
2022-09-27 2022-09-26 4 Dalal Anupam AADI Common Stock A - Award I 12,5000 320.000 4.000 1.849.402
2022-09-27 2022-09-26 4 Delaney Brendan AADI Common Stock A - Award D 12,5000 20.000 250 20.000
2022-09-27 2022-09-26 4 Giacobello Scott M. AADI Common Stock A - Award D 12,5000 20.000 250 20.000
2022-09-26 2022-09-22 4 Aghazadeh Behzad See footnotes AADI Common Stock, $0.0001 par value per share ("Common Stock") A - Award I 12,5000 1.260.000 15.750 3.471.752
2022-04-05 2022-04-01 4 ITRI LORETTTA M AADI Stock option (right to buy) A - Award D 17,24 67.300 67.300
2022-04-05 2022-04-01 4 Delaney Brendan AADI Stock option (right to buy) A - Award D 17,24 61.000 61.000
2022-04-05 2022-04-01 4 Giacobello Scott M. AADI Stock option (right to buy) A - Award D 17,24 46.400 46.400
2022-04-05 2022-04-01 4 Desai Neil AADI Stock option (right to buy) A - Award D 17,24 153.300 153.300
2022-03-22 2022-03-18 4 Desai Neil AADI Common Stock S - Sale I 20,0658 -3.550 -71 1.915.543
2021-10-25 2021-10-21 4 ITRI LORETTTA M AADI Stock option (right to buy) A - Award D 26,85 185.000 185.000
2021-10-25 3 ITRI LORETTTA M By spouse AADI Common Stock I 3.000
2021-09-22 2021-09-20 4 Delaney Brendan AADI Stock option (right to buy) A - Award D 29,09 260.000 260.000
2021-09-10 2021-09-08 4 Desai Neil AADI Stock option (right to buy) A - Award D 27,67 125.000 125.000
2021-09-10 2021-09-08 4 Reeve Emma AADI Stock option (right to buy) A - Award D 27,67 16.486 16.486
2021-08-31 2021-08-27 4 Hehenberger Karin M. AADI Stock option (right to buy) A - Award D 26,00 17.549 17.549
2021-08-31 2021-08-27 4 Maroun Richard E AADI Stock option (right to buy) A - Award D 26,00 17.549 17.549
2021-08-31 3 Desai Neil AADI Common Stock I 1.919.093
2021-08-31 3 Desai Neil AADI Common Stock I 639.698
2021-08-31 2021-08-26 4/A Dalal Anupam AADI Common Stock P - Purchase I 13,0770 1.529.402 20.000 1.529.402
2021-08-30 2021-08-27 4 Castelein Caley AADI Stock option (right to buy) A - Award D 26,00 17.549 17.549
2021-08-30 2021-08-26 4 Castelein Caley AADI Common Stock P - Purchase I 13,0770 259.998 3.400 259.998
2021-08-30 2021-08-27 4 Dalal Anupam AADI Stock option (right to buy) A - Award D 26,00 17.549 17.549
2021-08-30 2021-08-26 4 Dalal Anupam AADI Common Stock P - Purchase I 13,0770 1.529.402 20.000 1.529.402
2021-08-30 2021-08-27 4 Aghazadeh Behzad AADI Stock option (right to buy) A - Award D 26,00 17.549 17.549
2021-08-30 2021-08-26 4 Aghazadeh Behzad See footnotes AADI Common Stock, $0.0001 par value per share ("Common Stock") A - Award I 13,0770 1.911.752 25.000 2.211.752
2021-08-30 3 Avoro Ventures LLC See footnotes AADI Common Stock, par value $0.0001 per share I 300.000
2021-07-02 2021-06-30 4 Castelein Caley ARPO Common Stock A - Award D 1,5200 7.811 12 295.414
2021-07-02 2021-06-30 4 Prelack Steven ARPO Common Stock A - Award D 1,5200 12.334 19 24.485
2021-07-02 2021-06-30 4 Cohen Cheryl ARPO Common Stock A - Award D 1,5200 8.140 12 16.160
2021-07-02 2021-06-30 4 Dalal Anupam ARPO Common Stock A - Award D 1,5200 7.400 11 16.959
2021-07-02 2021-06-30 4 Dugel Pravin ARPO Common Stock A - Award D 1,5200 6.331 10 12.568
2021-06-22 2021-06-17 4 Cohen Cheryl ARPO Stock Option (Right to Buy) A - Award D 1,87 100.000 100.000
2021-04-02 2021-03-31 4 Dalal Anupam ARPO Common Stock A - Award D 1,5430 7.290 11 9.559
2021-04-02 2021-03-31 4 Prelack Steven ARPO Common Stock A - Award D 1,5430 12.151 19 12.151
2021-04-02 2021-03-31 4 Castelein Caley ARPO Common Stock A - Award D 1,5430 7.696 12 287.603
2021-04-02 2021-03-31 4 Dugel Pravin ARPO Common Stock A - Award D 1,5430 6.237 10 6.237
2021-04-02 2021-03-31 4 Cohen Cheryl ARPO Common Stock A - Award D 1,5430 8.020 12 8.020
2021-02-03 2021-02-01 4 Dugel Pravin ARPO Stock Option (Right to Buy) A - Award D 1,46 17.857 17.857
2021-02-03 2021-02-01 4 Cohen Cheryl ARPO Stock Option (Right to Buy) A - Award D 1,46 17.857 17.857
2021-02-03 2021-02-01 4 Dalal Anupam ARPO Stock Option (Right to Buy) A - Award D 1,46 17.857 17.857
2021-02-03 2021-02-01 4 Castelein Caley ARPO Stock Option (Right to Buy) A - Award D 1,46 17.857 17.857
2020-12-10 2020-12-08 4 ORBIMED ADVISORS LLC See Footnotes ARPO Stock Option (Right to Buy) X - Other I 0,96 -21.400 0
2020-12-10 2020-12-08 4 ORBIMED ADVISORS LLC See Footnotes ARPO Common Stock S - Sale I 1,9600 -21.400 -42 0
2020-12-10 2020-12-08 4 ORBIMED ADVISORS LLC See Footnotes ARPO Common Stock X - Other I 0,9600 21.400 21 21.400
2020-06-26 2020-06-24 4 Cohen Cheryl ARPO Stock Option (Right to Buy) A - Award D 1,22 52.144 52.144
2020-06-26 2020-06-24 4 Prelack Steven ARPO Stock Option (Right to Buy) A - Award D 1,22 52.144 52.144
2020-06-26 2020-06-24 4 Castelein Caley ARPO Stock Option (Right to Buy) A - Award D 1,22 52.144 52.144
2020-06-26 2020-06-24 4 Dalal Anupam ARPO Stock Option (Right to Buy) A - Award D 1,22 52.144 52.144
2020-06-26 2020-06-24 4 Dugel Pravin ARPO Stock Option (Right to Buy) A - Award D 1,22 52.144 52.144
2020-03-18 2020-03-16 4 Marek Regina ARPO Stock Option (Right to Buy) A - Award D 0,52 93.000 93.000
2020-03-18 2020-03-16 4 PETERS KEVIN G. ARPO Stock Option (Right to Buy) A - Award D 0,52 129.000 129.000
2020-03-18 2020-03-16 4 Gardner Joseph H. ARPO Stock Option (Right to Buy) A - Award D 0,52 155.000 155.000
2019-11-06 2019-11-04 4 Marek Regina ARPO Stock Option (Right to Buy) A - Award D 0,56 44.300 44.300
2019-10-24 3 Marek Regina ARPO Common Stock D 23.250
2019-10-24 3 Marek Regina ARPO Common Stock D 23.250
2019-10-24 3 Marek Regina ARPO Common Stock D 23.250
2019-07-10 2019-07-10 4 Gardner Joseph H. ARPO Common Stock P - Purchase D 0,8147 5.000 4 453.019
2019-07-08 2019-07-03 4 Gardner Joseph H. ARPO Common Stock P - Purchase D 0,8970 5.000 4 448.019
2019-06-19 2019-06-18 4 Prelack Steven ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-06-19 2019-06-18 4 Cohen Cheryl ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-06-19 2019-06-18 4 Dugel Pravin ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-06-19 2019-06-18 4 Satter Muneer A ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-06-19 2019-06-18 4 Khuong Chau Quang ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-06-19 2019-06-18 4 Castelein Caley ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-06-19 2019-06-18 4 Dalal Anupam ARPO Stock Option (Right to Buy) A - Award D 0,96 21.400 21.400
2019-05-16 2019-05-14 4 PETERS KEVIN G. ARPO Stock Option (Right to Buy) A - Award D 1,04 266.550 266.550
2019-05-16 2019-05-14 4 PETERS KEVIN G. ARPO Stock Option (Right to Buy) A - Award D 1,04 63.250 63.250
2019-05-16 2019-05-14 4 ROGERS MICHAEL W ARPO Stock Option (Right to Buy) A - Award D 1,04 430.500 430.500
2019-05-16 2019-05-14 4 ROGERS MICHAEL W ARPO Stock Option (Right to Buy) A - Award D 1,04 169.500 169.500
2019-05-16 2019-05-14 4 Gardner Joseph H. ARPO Stock Option (Right to Buy) A - Award D 1,04 349.350 349.350
2019-05-16 2019-05-14 4 HOFFMAN STEPHEN J ARPO Stock Option (Right to Buy) A - Award D 1,04 709.050 709.050
2019-04-29 2019-04-26 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0300 -138.704 -143 4.049.804
2019-04-29 2019-04-25 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0300 -563.096 -580 4.188.508
2019-04-24 2019-04-24 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0300 -16.403 -17 4.751.604
2019-04-24 2019-04-23 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0300 -27.554 -28 4.768.007
2019-04-24 2019-04-22 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9700 -7.100 -7 4.795.561
2019-04-15 2019-04-15 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9900 -28.794 -29 4.802.661
2019-04-15 2019-04-12 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0400 -30.908 -32 4.831.455
2019-04-15 2019-04-11 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0800 -57.438 -62 4.862.363
2019-04-10 2019-04-10 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0900 -140.230 -153 4.919.801
2019-04-10 2019-04-09 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0100 -32.991 -33 5.060.031
2019-04-10 2019-04-08 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0200 -27.525 -28 5.093.022
2019-04-05 2019-04-05 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0200 -24.661 -25 5.120.547
2019-04-05 2019-04-04 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0100 -47.900 -48 5.145.208
2019-04-05 2019-04-03 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9600 -58.033 -56 5.193.108
2019-04-02 2019-04-02 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9700 -51.754 -50 5.251.141
2019-04-02 2019-04-01 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9500 -116.909 -111 5.302.895
2019-04-02 2019-03-29 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9100 -63.100 -57 5.419.804
2019-03-28 2019-03-28 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9400 -88.835 -84 5.482.904
2019-03-28 2019-03-27 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 0,9900 -50.749 -50 5.571.739
2019-03-28 2019-03-26 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 1,0100 -177.762 -180 5.622.488
2019-02-20 2019-02-15 4 ROGERS MICHAEL W ARPO Stock Option (Right to Buy) A - Award D 3,27 215.328 215.328
2019-02-20 2019-02-15 4 PETERS KEVIN G. ARPO Stock Option (Right to Buy) A - Award D 3,27 125.000 125.000
2019-02-20 2019-02-15 4 HOFFMAN STEPHEN J ARPO Stock Option (Right to Buy) A - Award D 3,27 365.000 365.000
2019-02-20 2019-02-15 4 Gardner Joseph H. ARPO Stock Option (Right to Buy) A - Award D 3,27 150.000 150.000
2019-02-20 2019-02-15 4 PAKOLA STEVE ARPO Stock Option (Right to Buy) A - Award D 3,27 125.000 125.000
2019-02-13 2018-12-12 5 Gardner Joseph H. ARPO Common Stock G - Gift I 150.000 150.000
2019-02-13 2018-12-12 5 Gardner Joseph H. ARPO Common Stock G - Gift D -150.000 443.019
2019-01-10 2019-01-10 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,4537 23.818 58 5.621.835
2019-01-10 2019-01-09 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,3938 20.000 48 5.598.017
2019-01-10 2019-01-08 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,1986 20.000 44 5.578.017
2019-01-07 2019-01-07 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,1779 20.000 44 5.558.017
2019-01-07 2019-01-04 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,1198 20.000 42 5.538.017
2019-01-07 2019-01-03 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0754 20.000 42 5.518.017
2019-01-02 2019-01-02 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,9419 20.000 39 5.498.017
2019-01-02 2018-12-31 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,7450 20.000 35 5.478.017
2019-01-02 2018-12-28 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,7186 20.000 34 5.458.017
2018-12-27 2018-12-27 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,6705 20.000 33 5.438.017
2018-12-27 2018-12-26 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,6927 20.000 34 5.418.017
2018-12-27 2018-12-21 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,8435 20.000 37 5.398.017
2018-12-20 2018-12-20 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,8492 20.000 37 5.378.017
2018-12-20 2018-12-19 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,9192 20.000 38 5.358.017
2018-12-20 2018-12-18 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,9928 20.000 40 5.338.017
2018-12-14 2018-12-14 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0047 20.000 40 5.318.017
2018-12-14 2018-12-13 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0154 20.000 40 5.298.017
2018-12-14 2018-12-12 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0469 20.000 41 5.278.017
2018-12-11 2018-12-11 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0923 20.000 42 5.258.017
2018-12-11 2018-12-10 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,1304 20.000 43 5.238.017
2018-12-11 2018-12-07 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,1394 20.000 43 5.218.017
2018-12-06 2018-12-06 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,1792 20.000 44 5.198.017
2018-12-06 2018-12-04 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0997 20.000 42 5.178.017
2018-12-06 2018-12-03 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,9887 20.000 40 5.158.017
2018-11-30 2018-11-30 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,9846 20.000 40 5.138.017
2018-11-30 2018-11-29 4 Satter Muneer A ARPO Common Stock P - Purchase I 2,0059 20.000 40 5.118.017
2018-11-30 2018-11-28 4 Satter Muneer A ARPO Common Stock P - Purchase I 1,9357 20.000 39 5.098.017
2018-11-16 2018-10-26 4 Dugel Pravin ARPO Stock Option (Right to Buy) A - Award D 2,05 2.500 2.500
2018-11-14 2018-11-12 4 HOFFMAN STEPHEN J ARPO Common Stock P - Purchase D 2,0100 30.000 60 31.967
2018-11-14 2018-11-09 4 HOFFMAN STEPHEN J ARPO Common Stock P - Purchase D 1,9500 1.967 4 1.967
2018-09-26 2018-09-24 4 Castelein Caley ARPO Common Stock D - Sale to Issuer I -1.603.526 0
2018-09-26 2018-09-24 4 Castelein Caley ARPO Common Stock J - Other D 268.987 279.907
2018-08-22 2018-08-20 4 Novartis Bioventures Ltd ARPO Common Stock S - Sale I 3,9000 -5.300 -21 5.800.250
2018-07-02 2018-06-28 4 ORBIMED ADVISORS LLC See Footnotes ARPO Common Stock P - Purchase I 3,8500 777.500 2.993 5.193.946
2018-07-02 2018-06-28 4 Khuong Chau Quang See Footnotes ARPO Common Stock P - Purchase I 3,8500 777.500 2.993 5.193.946
2018-06-29 2018-06-28 4 Satter Muneer A ARPO Common Stock P - Purchase I 3,8500 1.818.182 7.000 5.078.017
2018-06-22 2018-06-20 4 Dalal Anupam ARPO Stock Option (Right to Buy) A - Award D 4,00 21.400 21.400
2018-06-22 2018-06-20 4 Satter Muneer A ARPO Stock Option (Right to Buy) A - Award D 4,00 21.400 21.400
2018-06-22 2018-06-20 4 Castelein Caley ARPO Stock Option (Right to Buy) A - Award D 4,00 21.400 21.400
2018-06-22 2018-06-20 4 Prelack Steven ARPO Stock Option (Right to Buy) A - Award D 4,00 21.400 21.400
2018-06-22 2018-06-20 4 Dugel Pravin ARPO Stock Option (Right to Buy) A - Award D 4,00 21.400 21.400
2018-06-22 2018-06-20 4 Khuong Chau Quang ARPO Stock Option (Right to Buy) A - Award D 4,00 21.400 21.400
2018-06-22 2018-06-20 4 Cohen Cheryl ARPO Stock Option (Right to Buy) A - Award D 4,00 42.800 42.800
2018-05-21 3 DESAI DHAVAL ARPO Common Stock D 150.684
2018-05-21 3 DESAI DHAVAL ARPO Common Stock D 150.684
2018-05-21 3 DESAI DHAVAL ARPO Common Stock D 150.684
2018-04-25 2018-04-23 4 Gardner Joseph H. ARPO Stock Option (Right to Buy) A - Award D 3,59 150.000 150.000
2018-04-25 2018-04-23 4 PAKOLA STEVE ARPO Stock Option (Right to Buy) A - Award D 3,59 100.000 100.000
2018-04-25 2018-04-23 4 ROGERS MICHAEL W ARPO Stock Option (Right to Buy) A - Award D 3,59 144.000 144.000
2018-04-25 2018-04-23 4 PETERS KEVIN G. ARPO Stock Option (Right to Buy) A - Award D 3,59 100.000 100.000
2018-04-25 2018-04-23 4 HOFFMAN STEPHEN J ARPO Stock Option (Right to Buy) A - Award D 3,59 300.000 300.000
2018-03-23 2018-03-23 4 Satter Muneer A ARPO Common Stock P - Purchase I 5,0000 1.000 5 3.259.835
2018-03-23 2018-03-21 4 Satter Muneer A ARPO Common Stock P - Purchase I 4,8475 4.000 19 3.258.835
2018-03-21 2018-03-20 4 Satter Muneer A ARPO Common Stock P - Purchase I 4,9741 5.400 27 3.254.835
2018-03-21 2018-03-19 4 Satter Muneer A ARPO Common Stock P - Purchase I 4,9638 7.600 38 3.249.435
2018-02-14 2017-12-22 5 Dalal Anupam ARPO Common Stock J - Other D 2.269 2.269
2018-02-14 2017-12-22 5 Dalal Anupam ARPO Common Stock J - Other I -7.882 0
2018-02-14 2017-12-22 5 Castelein Caley ARPO Common Stock J - Other I 10.920 10.920
2018-02-14 2017-12-22 5 Castelein Caley ARPO Common Stock J - Other I -7.882 1.603.526
2017-12-18 2017-12-14 4 ROGERS MICHAEL W ARPO Stock Option (Right to Buy) A - Award D 5,50 5,5000 293.006 1.612 0
2017-12-18 2017-12-14 4 Gardner Joseph H. ARPO Stock Option (Right to Buy) A - Award D 5,50 5,5000 135.000 742 0
2017-12-18 2017-12-14 4 HOFFMAN STEPHEN J ARPO Stock Option (Right to Buy) A - Award D 5,50 5,5000 586.012 3.223 0
2017-03-17 3 Khuong Chau Quang See Footnotes NONE Common Stock I 7.306.902
2017-03-17 3 Khuong Chau Quang See Footnotes NONE Common Stock I 7.306.902
2017-03-17 3 PETERS KEVIN G. NONE Common Stock D 633.788
2017-03-17 3 PETERS KEVIN G. NONE Common Stock D 633.788
2017-03-17 3 Dalal Anupam NONE Common Stock I 15.764
2017-03-17 3 Dalal Anupam NONE Common Stock I 15.764
2017-03-17 3 Gardner Joseph H. NONE Common Stock D 986.046
2017-03-17 3 Gardner Joseph H. NONE Common Stock D 986.046
2017-03-17 3 Castelein Caley See Footnotes NONE Common Stock I 2.422.816
2017-03-17 3 Castelein Caley See Footnotes NONE Common Stock I 2.422.816
2017-03-17 3 WEISS PAUL M See Footnotes NONE Common Stock I 2.607.730
2017-03-17 3 WEISS PAUL M See Footnotes NONE Common Stock I 2.607.730
2017-03-17 3 ISALY SAMUEL D See Footnotes NONE Common Stock I 7.306.902
2017-03-17 3 ISALY SAMUEL D See Footnotes NONE Common Stock I 7.306.902
2017-03-17 3 ISALY SAMUEL D See Footnotes NONE Common Stock I 7.306.902
2017-03-17 3 ISALY SAMUEL D See Footnotes NONE Common Stock I 7.306.902
2017-03-17 3 NOVARTIS AG NONE Common Stock I 10.491.100
2017-03-17 3 NOVARTIS AG NONE Common Stock I 10.491.100
2017-03-17 3 NOVARTIS AG NONE Common Stock I 10.491.100
2017-03-17 3 Satter Muneer A NONE Common Stock I 4.243.670
2017-03-17 3 Satter Muneer A NONE Common Stock I 4.243.670
2017-03-17 2017-03-15 4 ORBIMED ADVISORS LLC See Footnotes NONE Common Stock P - Purchase I 5,0000 762.995 3.815 4.416.446
2017-03-17 2017-03-15 4 PETERS KEVIN G. NONE Common Stock P - Purchase D 5,0000 3.642 18 320.536
2017-03-17 2017-03-15 4 Khuong Chau Quang See Footnotes NONE Common Stock P - Purchase I 5,0000 762.995 3.815 4.416.446
2017-03-17 2017-03-15 4 Castelein Caley NONE Common Stock P - Purchase I 5,0000 400.000 2.000 1.611.408
2017-03-17 2017-03-15 4 Novartis Bioventures Ltd NONE Common Stock P - Purchase I 5,0000 560.000 2.800 5.805.550
2017-03-17 2017-03-15 4 WEISS PAUL M See Footnotes NONE Common Stock P - Purchase I 5,0000 272.302 1.362 1.576.167
2017-03-17 2017-03-15 4 Gardner Joseph H. NONE Common Stock P - Purchase D 5,0000 99.996 500 593.019
2017-03-17 2017-03-15 4 Satter Muneer A NONE Common Stock P - Purchase I 5,0000 1.120.000 5.600 3.241.835
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:3350 3,34 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista